Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory biotype of ADHD is linked to chronic stress: a data-driven analysis of the inflammatory proteome.
Schnorr I, Siegl A, Luckhardt S, Wenz S, Friedrichsen H, El Jomaa H, Steinmann A, Kilencz T, Arteaga-Henríquez G, Ramos-Sayalero C, Ibanez-Jimenez P, Rosales-Ortiz SK, Bitter I, Fadeuilhe C, Ferrer M, Lavebratt C, Réthelyi JM, Richarte V, Rommelse N, Ramos-Quiroga JA, Arias-Vasquez A, Resch E, Reif A, Matura S, Schiweck C. Schnorr I, et al. Among authors: ferrer m. Transl Psychiatry. 2024 Jan 18;14(1):37. doi: 10.1038/s41398-023-02729-3. Transl Psychiatry. 2024. PMID: 38238292 Free PMC article.
Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder.
Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gómez N, Yelmo S, Ferrer M, Martínez Y, Casas M. Ramos-Quiroga JA, et al. Among authors: ferrer m. CNS Drugs. 2008;22(7):603-11. doi: 10.2165/00023210-200822070-00005. CNS Drugs. 2008. PMID: 18547128 Clinical Trial.
The role of environmental influences in the complex relationship between borderline personality disorder and attention-deficit/hyperactivity disorder: review of recent findings.
Calvo N, Lara B, Serrat L, Pérez-Rodríguez V, Andión Ò, Ramos-Quiroga JA, Ferrer M. Calvo N, et al. Among authors: ferrer m. Borderline Personal Disord Emot Dysregul. 2020 Jan 6;7:2. doi: 10.1186/s40479-019-0118-z. eCollection 2020. Borderline Personal Disord Emot Dysregul. 2020. PMID: 31921426 Free PMC article. Review.
Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time.
Ferrer M, Soto-Angona Ó, Soler-Artigas M, Ibáñez P, Fadeuilhe C, Palma-Álvarez RF, Lidai R, Vargas-Cáceres S, Ángeles Torrecilla M, López A, Ramos-Quiroga JA. Ferrer M, et al. Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):482-490. doi: 10.9758/cpn.2022.20.3.482. Clin Psychopharmacol Neurosci. 2022. PMID: 35879032 Free PMC article.
Discrimination of Borderline Personality Disorder (BPD) and Attention-Deficit/Hyperactivity Disorder (ADHD) in adolescents: Spanish version of the Borderline Personality Features Scale for Children-11 Self-Report (BPFSC-11) Preliminary results.
Calvo N, Marin JL, Vidal R, Sharp C, Duque JD, Ramos-Quiroga JA, Ferrer M. Calvo N, et al. Among authors: ferrer m. Borderline Personal Disord Emot Dysregul. 2023 May 16;10(1):15. doi: 10.1186/s40479-023-00223-2. Borderline Personal Disord Emot Dysregul. 2023. PMID: 37189168 Free PMC article.
2,091 results